Caribou Biosciences, Inc.
CRBU
$1.44
-$0.10-6.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 112.31M | 117.63M | 139.34M | 147.26M | 183.95M |
| Total Receivables | 1.94M | 2.36M | 2.98M | 2.93M | 2.78M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.34M | 2.39M | 2.91M | 1.93M | 3.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 3.39M | 2.72M |
| Total Current Assets | 116.60M | 122.38M | 145.23M | 155.51M | 192.51M |
|
|
|||||
| Total Current Assets | 116.60M | 122.38M | 145.23M | 155.51M | 192.51M |
| Net Property, Plant & Equipment | 22.53M | 23.48M | 24.43M | 23.60M | 24.64M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.14M | 2.14M | 2.20M | 3.78M | 3.63M |
| Total Assets | 142.77M | 149.00M | 175.37M | 194.98M | 220.90M |
|
|
|||||
| Total Accounts Payable | 3.08M | 3.50M | 5.78M | 3.80M | 3.24M |
| Total Accrued Expenses | 11.45M | 13.16M | 15.72M | 17.49M | 18.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.38M | 1.29M | 1.20M | 2.69M | 2.29M |
| Total Finance Division Other Current Liabilities | 2.07M | 1.73M | 2.71M | 4.08M | 4.90M |
| Total Other Current Liabilities | 2.07M | 1.73M | 2.71M | 4.08M | 4.90M |
| Total Current Liabilities | 17.97M | 19.67M | 25.41M | 28.06M | 28.89M |
|
|
|||||
| Total Current Liabilities | 17.97M | 19.67M | 25.41M | 28.06M | 28.89M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.28M | 25.66M | 26.03M | 22.78M | 23.56M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.42M | 1.65M | 1.75M | 2.30M | 2.32M |
| Total Liabilities | 44.67M | 46.98M | 53.19M | 53.14M | 54.77M |
|
|
|||||
| Common Stock & APIC | 744.06M | 723.64M | 718.59M | 711.78M | 708.57M |
| Retained Earnings | -645.88M | -621.60M | -596.52M | -570.03M | -542.48M |
| Treasury Stock & Other | -71.00K | -23.00K | 103.00K | 93.00K | 40.00K |
| Total Common Equity | 98.10M | 102.02M | 122.18M | 141.85M | 166.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 98.10M | 102.02M | 122.18M | 141.85M | 166.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 98.10M | 102.02M | 122.18M | 141.85M | 166.13M |
|
|
|||||